{
    "nctId": "NCT03011177",
    "officialTitle": "A Randomized, Open Label, Parallel-group, Non-inferiority, Active-controlled, Phase \u2163 Study to Evaluate the Efficacy and Safety of Teneligliptin Versus Linagliptin in Type 2 Diabetes Mellitus Patients",
    "inclusionCriteria": "* Patients who are 19 years or older on screening\n* Patients with type 2 diabetes mellitus\n* Patients with 7.0% \u2264 HbA1c \u2264 11.0% at the screening visit\n* Patients with Fasting Plasma Glucose \\<15mmol/L(270mg/dL) on screening\n* Must have minimum age of 19 Years",
    "exclusionCriteria": "-"
}